The prevalence of malignant neoplasms of the kidney in Saint Petersburg and various regions of Russia in 2016-2021

Cover Page

Cite item

Full Text

Abstract

Background. Currently, kidney cancer remains one of the most common oncourological diseases with relatively high mortality rate.

Aim. To study the main epidemiological indicators of malignant neoplasms of the kidney in various regions of Russia and Saint Petersburg.

Materials and methods. Based on the data from the Department of Medical Statistics of Tumor Diseases of the Medical Information and Analytical Center, the epidemiological indicators of malignant neoplasms of the kidney for the period between 2016 and 2021 in Russia, individual Federal Districts of the country and Saint Petersburg were analyzed.

Results. Despite the  increase in the  prevalence of malignant  neoplasms of the  kidney,  medical oncological care for the population is at an appropriate level. Most cases of the disease are diagnosed at early stages, there is a decrease in patient mortality rates and an increase in 5-year survival, which indicates the effectiveness of ongoing anticancer measures. In a number of Federal Districts, a number of indicators showed a negative trend compared to the all-Russia data, which requires close attention.

Conclusion. The analysis of statistical  data of patients with malignant neoplasms of the kidney can be used to optimize the algorithms for diagnosing and treating  this category of patients,  as well as to improve oncological care for the population.

About the authors

S. V. Popov

St. Luka’s Clinical Hospital

Email: doc.popov@gmail.com
ORCID iD: 0000-0003-2767-7153

46 Chugunnaya St., Saint Petersburg 194044

Russian Federation

R. G. Guseynov

St. Luka’s Clinical Hospital; Saint Petersburg State University

Email: rusfa@yandex.ru
ORCID iD: 0000-0001-9935-0243

46 Chugunnaya St., Saint Petersburg 194044; 7-9 Universitetskaya Naberezhnaya, Saint Petersburg 199034

Russian Federation

I. N. Orlov

St. Luka’s Clinical Hospital

Email: info@lucaclinic.ru

46 Chugunnaya St., Saint Petersburg 194044

Russian Federation

V. V. Khizha

St. Luka’s Clinical Hospital; Medical Information and Analytical Center, Ministry of Health of Russia

Email: apink1@yandex.ru
ORCID iD: 0000-0002-4218-0228

46 Chugunnaya St., Saint Petersburg 194044; 30 Shkapina St., Saint Petersburg 198095

Russian Federation

A. V. Yazenok

St. Luka’s Clinical Hospital; Medical Information and Analytical Center, Ministry of Health of Russia

Email: AYazenok@spbmiac.ru
ORCID iD: 0000-0002-1334-8191

46 Chugunnaya St., Saint Petersburg 194044; 30 Shkapina St., Saint Petersburg 198095

Russian Federation

K. V. Sivak

St. Luka’s Clinical Hospital

Email: kvsivak@gmail.com
ORCID iD: 0000-0003-4064-5033

46 Chugunnaya St., Saint Petersburg 194044

Russian Federation

V. V. Perepelitsa

St. Luka’s Clinical Hospital

Email: perepelitsa_vit@mail.ru
ORCID iD: 0000-0002-7656-4473

46 Chugunnaya St., Saint Petersburg 194044

Russian Federation

N. S. Bunenkov

St. Luka’s Clinical Hospital; I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia; V.A. Almazov National Medical Research Centre, Ministry of Health of Russia

Author for correspondence.
Email: bunenkov2006@yandex.ru
ORCID iD: 0000-0003-4331-028X

Nikolay S. Bunenkov.

46 Chugunnaya St., Saint Petersburg 194044; 6-8 L’va Tolstogo St., Saint Petersburg 197022; 2 Akkuratova St., Saint Petersburg 197341

Russian Federation

A. S. Ulitina

St. Luka’s Clinical Hospital

Email: anna.s.ulitina@yandex.ru
ORCID iD: 0000-0003-3011-1812

46 Chugunnaya St., Saint Petersburg 194044

Russian Federation

References

  1. Gray R.E., Harris G.T. Renal cell carcinoma: diagnosis and management. Am Fam Physician 2019;99(3):179–84.
  2. State of oncological care in Russia in 2021. Eds.: А.D. Kaprin, V.V. Starinskiy, A.O. Shachzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2022. 239 p. (In Russ.).
  3. Tahbaz R., Schmid M., Merseburger A.S. Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition. Curr Opin Urol 2018;28(1):62–79. doi: 10.1097/MOU.0000000000000454
  4. Nosov А.K., Lushina P.A. Kidney cancer incidence and mortality in Russia and Saint-Petersburg. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology 2017;16(5):95–103. (In Russ.). doi: 10.21294/1814-4861-2017-16-5-95-103
  5. Merabishvili V.M. Malignant neoplasms in Saint Petersburg. Saint Petersburg, 2015. 295 p. (In Russ.).
  6. Capitanio U., Bensalah K., Bex A. et al. Epidemiology of renal cell carcinoma. Eur Urol 2019;75(1):74–84. doi: 10.1016/j.eururo.2018.08.036
  7. State of oncological care in Russia in 2016. Eds.: А.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2017. 236 p. (In Russ.).
  8. State of oncological care in Russia in 2017. Eds.: А.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2018. 236 p. (In Russ.).
  9. State of oncological care in Russia in 2018. Eds.: А.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2019. 236 p. (In Russ.).
  10. State of oncological care in Russia in 2019. Eds.: А.D. Kaprin, V.V. Starinskiy, A.O. Shachzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2020. 236 p. (In Russ.).
  11. State of oncological care in Russia in 2020. Eds.: А.D. Kaprin, V.V. Starinskiy, A.O. Shachzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2021. 239 p. (In Russ.).
  12. Merabishvili M.V. Oncological statistics (traditional methods, new information technologies). Guidelines for physicians. 2nd edn., enlarged. Part I. Saint Petersburg, 2015. 223 p. (In Russ.).
  13. Harrison H., Thompson R.E., Lin Z. et al. Risk prediction models for kidney cancer: a systematic review. Eur Urol Focus 2021;7(6):1380–90. doi: 10.1016/j.euf.2020.06.024
  14. Gaas M.Ya., Kaprin A.D., Vorobyev N.V. et al. Predictors of local recurrence of renal cell cancer. Our experience. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology 2022;21(4):16–24. (In Russ.). doi: 10.21294/1814-4861-2022-21-4-16-24
  15. Cheung D., Frankel J., Tut P. et al. Treatment on active surveillance of small renal masses: progression vs. preference. Can Urol Assoc J 2022;16(4):97–101. doi: 10.5489/cuaj.7451
  16. Popov S.V., Guseynov R.G., Orlov I.N. et al. Evaluation of quality of life of patients after surgical treatment of kidney cancer. Onkourologiya = Cancer Urology 2019;15(2):25–34. (In Russ.). doi: 10.17650/1726-9776-2019-15-2-25-34

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c)


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36986 от  21.07.2009.